We send the latest information from SMC Laboratories.
2026.03.13
EVENT
MASH Resmetirom
SMC Laboratories is pleased to host a webinar titled “Preclinical MASH Models and Standard-of-Care Data,” focu…
2026.03.06
PUBLICATION
SMC Laboratories is pleased to announce that our research abstract has been accepted for a poster presentation…
2026.02.19
NEWS RELEASE
HCC immuno-oncology Liver cancer MASH STAM
February 19, 2026 SMC Laboratories, Inc. (“SMC”) today announced the initiation of a collaborative development…
2026.02.13
UPDATE
MASH STAM
Devonian Health Group announced the availability of additional molecular data from a preclinical study using a…
2026.02.11
We will be participating in Digital Partnering, a global virtual partnering event for the life sciences indust…
2026.01.30
We are pleased to announce an upcoming webinar focused on the evaluation of immunotherapy in hepatocellular ca…
2026.01.15
PRODUCTS AND SERVICE
SMC Laboratories has introduced Resmetirom, a THR-β agonist, as a positive control in the CDAHFD model for non…
2025.12.29
We sincerely thank you for your continued support and collaboration with SMC Laboratories throughout 2025. Thi…
2025.12.25
SMC Laboratories will participate in BIO Partnering™ @JPM Week 2026, held in January 2026 during JPM Healthcar…
2025.12.04
We are pleased to announce that our abstract has been accepted for poster presentation at the ISN World Congre…
2025.11.27
SMC Laboratories will participate in the international online partnering event“Biotechgate Digital Partnering”…
2025.11.18
SMC Laboratories will present a poster at the 267th Kanto Branch Meeting of the Japan Respiratory Society, to …
This website uses cookies to improve your browsing experience and to measure the effectiveness of our advertising.Please see our Privacy Policy for more information.
